Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration

Parasites and Vectors

Volumn 7, Issue 1, 2014, Pages

  Kilp, Susanne ^a   Ramirez, Diana ^b   Allan, Mark J ^a   Roepke, Rainer Ka ^a   Nuernberger, Martin C ^a  

^a Intervet Innovation GmbH   (Germany)

^b Harlan   (Switzerland)

Author keywords

Dog; Fluralaner; Intravenous; Oral; Pharmacokinetics

Indexed keywords

FLURALANER; A1443 COMPOUND; ACARICIDE; ANTIPARASITIC AGENT; INSECTICIDE; ISOXAZOLE DERIVATIVE; SOLUTION AND SOLUBILITY; TABLET;

AREA UNDER THE CURVE; ARTICLE; CIRCULATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RETENTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER BLOOD FLOW; LIVER CLEARANCE; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHARMACOKINETICS; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; BLOOD; CONTROLLED STUDY; DOG; DOSE RESPONSE; HALF LIFE TIME; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SAFETY; SOLUTION AND SOLUBILITY; TABLET;

CANIS FAMILIARIS; IXODIDA; SIPHONAPTERA (FLEAS);

ACARICIDES; ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ANIMALS; ANTIPARASITIC AGENTS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALF-LIFE; INSECTICIDES; ISOXAZOLES; MALE; PHARMACEUTICAL SOLUTIONS; SAFETY; TABLETS;

EID: 84898541319     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-7-85     Document Type: Article

References (9)

1. TM (fipronil) in flea- and tick-infested dogs. Rohdich N, Roepke RKA, Zschiesche E, Parasit Vectors 2014 7 83 10.1186/1756-3305-7-83 24593931
2. The novel isoxazoline ectoparasiticide fluralaner: selective inhibition of arthropod γ-aminobutyric acid- and L-glutamate-gated chloride channels and insecticidal/acaricidal activity. Gassel M, Wolf C, Noack S, Williams H, Ilg T, Insect Biochem Mol Biol 2014 45 111 124 24365472
3. The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels. Ozoe Y, Asahi M, Ozoe F, Nakahira K, Mita T, Biochem Biophys Res Commun 2010 391 744 749 10.1016/j.bbrc.2009.11.131 19944072
4. The effect of food on the pharmacokinetics of oral fluralaner in dogs. Walther FM, Allan MJ, Roepke RKA, Nuernberger MC, Parasit Vectors 2014 7 84 10.1186/1756-3305-7-84 24598049
5. OECD, Series on Principles of Good Laboratory Practice and Compliance Monitoring No.1. OECD Principles of Good Laboratory Practice (as revised in 1997) Paris: OECD Environmental Health and Safety Publications, ENV/MC/CHEM(98)17 1998
6. Physiological parameters in laboratory animals and humans. Davies B, Morris T, Pharm Res 1993 10 7 1093 1095 10.1023/A:1018943613122 8378254 (Pubitemid 23211439)
7. Clearance. Toutain PL, Bousquet-Mélou A, J Vet Pharmacol Ther 2004 27 415 425 10.1111/j.1365-2885.2004.00605.x 15601437 (Pubitemid 39665129)
8. Plasma terminal half life. Toutain PL, Bousquet-Mélou A, J Vet Pharmacol Ther 2004 27 427 439 10.1111/j.1365-2885.2004.00600.x 15601438 (Pubitemid 39665130)
9. Volumes of distribution. Toutain PL, Bousquet-Mélou A, J Vet Pharmacol Ther 2004 27 441 453 10.1111/j.1365-2885.2004.00602.x 15601439 (Pubitemid 39665131)